Literature DB >> 2169896

Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate.

S Masure1, A Billiau, J Van Damme, G Opdenakker.   

Abstract

Several human cell lines were studied for the production of gelatinases. Diploid fibroblasts, the melanoma cell line Bowes, the MG-63 osteosarcoma cell line and the human hepatoma cell line Malavu all constitutively produced a 67 kDa gelatinase. Gelatinolytic enzymes were quantified by a sensitive zymographic substrate conversion assay. Upon induction with phorbol 12-myristate 13-acetate (PMA), the human hepatoma cell line secreted considerable amounts of an 85 kDa gelatinase activity. The induction process was time- and dose-dependent. It represented a true increase in production per individual cell and was associated by a marked change of the cell morphology. The effect of various proteinase inhibitors and the maximal activity of the enzyme near neutral pH demonstrate that it is a neutral metalloproteinase. Characterization studies showed the 85 kDa gelatinase to be transformed to lower molecular weight, active forms by treatment with p-aminophenylmercuric acetate (APMA) or trypsin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169896     DOI: 10.1016/0167-4889(90)90103-k

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Zymography methods for visualizing hydrolytic enzymes.

Authors:  Jennifer Vandooren; Nathalie Geurts; Erik Martens; Philippe E Van den Steen; Ghislain Opdenakker
Journal:  Nat Methods       Date:  2013-03       Impact factor: 28.547

2.  Human gelatinase B, a marker enzyme in rheumatoid arthritis, is inhibited by D-penicillamine: anti-rheumatic activity by protease inhibition.

Authors:  K Norga; B Grillet; S Masure; L Paemen; G Opdenakker
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

3.  Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9).

Authors:  J F Pruijt; W E Fibbe; L Laterveer; R A Pieters; I J Lindley; L Paemen; S Masure; R Willemze; G Opdenakker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

4.  Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle.

Authors:  E Van Coillie; I Van Aelst; A Wuyts; R Vercauteren; R Devos; C De Wolf-Peeters; J Van Damme; G Opdenakker
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

5.  Functional Roles of N-Linked Glycosylation of Human Matrix Metalloproteinase 9.

Authors:  Tyler Duellman; John Burnett; Jay Yang
Journal:  Traffic       Date:  2015-09-02       Impact factor: 6.215

6.  Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.

Authors:  S Zucker; P Mancuso; B DiMassimo; R M Lysik; C Conner; C L Wu
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

7.  In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection.

Authors:  Pasqua Gramegna; Tiziana Latronico; Maria Teresa Branà; Gaetano Di Bari; Fabio Mengoni; Valeria Belvisi; Maria T Mascellino; Miriam Lichtner; Vincenzo Vullo; Claudio M Mastroianni; Grazia M Liuzzi
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

8.  Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.

Authors:  Antonietta Rosella Farina; Andrew Reay Mackay
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.